Total Payments
$2,418
2024 Payments
$711.10
Companies
22
Transactions
149
Medicare Patients
1,579
Medicare Billing
$133,391

Payment Breakdown by Category

Food & Beverage$2,418 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,418 149 100.0%

Top Paying Companies

Company Total Records Latest Year
Lilly USA, LLC $462.36 30 $0 (2024)
PFIZER INC. $414.64 30 $0 (2024)
GlaxoSmithKline, LLC. $274.79 15 $0 (2024)
ABBVIE INC. $171.01 8 $0 (2024)
AstraZeneca Pharmaceuticals LP $144.59 10 $0 (2024)
Exact Sciences Corporation $125.68 7 $0 (2024)
Novo Nordisk Inc $120.21 7 $0 (2024)
Astellas Pharma US Inc $107.83 6 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $87.60 5 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $85.32 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $711.10 39 Lilly USA, LLC ($101.09)
2023 $726.09 43 Lilly USA, LLC ($214.21)
2022 $367.79 23 Lilly USA, LLC ($123.11)
2021 $434.64 32 PFIZER INC. ($209.07)
2020 $145.87 10 PFIZER INC. ($119.52)
2019 $32.76 2 Boehringer Ingelheim Pharmaceuticals, Inc. ($16.65)

All Payment Transactions

149 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/30/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $16.25 General
Category: Diabetes
11/28/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $19.23 General
Category: PSYCHIATRY
11/19/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $16.50 General
Category: Oncology
11/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.73 General
Category: NEUROSCIENCE
10/31/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $20.17 General
Category: Biological
10/15/2024 Kowa Pharmaceuticals America, Inc. ZORYVE (Drug) Food and Beverage In-kind items and services $14.30 General
Category: DERMATOLOGY
09/24/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.02 General
Category: NEUROSCIENCE
09/20/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $16.43 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
09/18/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $18.61 General
Category: NEUROSCIENCE
08/20/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $17.25 General
Category: Diabetes
08/13/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.06 General
Category: NEUROSCIENCE
08/06/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.12 General
Category: RESPIRATORY
07/31/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $19.22 General
Category: Respiratory
07/30/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $17.52 General
Category: Oncology
07/23/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $17.90 General
Category: Biological
07/18/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $22.15 General
Category: Diabetes Care
06/27/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $18.32 General
Category: VACCINES
06/25/2024 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage Cash or cash equivalent $15.03 General
Category: ADHD
05/28/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $21.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
05/23/2024 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage Cash or cash equivalent $15.38 General
Category: ADHD
05/22/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.19 General
Category: Diabetes
05/16/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $20.44 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
05/15/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $18.21 General
Category: Endocrinology
05/06/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $14.28 General
Category: Diabetes
05/02/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $21.93 General
Category: Biological

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 367 496 $72,308 $31,416
2022 11 426 553 $89,978 $36,840
2021 14 475 699 $98,719 $41,909
2020 10 311 379 $62,960 $23,225
Total Patients
1,579
Total Services
2,127
Medicare Billing
$133,391
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 94 170 $35,020 $12,552 35.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 64 64 $11,840 $7,724 65.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 68 110 $15,400 $6,126 39.8%
90662 Influenza vaccine split virus, preservative free Office 2023 22 22 $2,332 $1,579 67.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $3,312 $1,180 35.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 18 19 $1,387 $739.80 53.3%
G0008 Administration of influenza virus vaccine Office 2023 23 23 $966.00 $666.77 69.0%
G0009 Administration of pneumococcal vaccine Office 2023 11 11 $462.00 $318.89 69.0%
83036 Hemoglobin a1c level Office 2023 28 33 $1,188 $314.16 26.4%
36415 Insertion of needle into vein for collection of blood sample Office 2023 27 32 $401.00 $215.88 53.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 110 180 $37,080 $13,376 36.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 56 56 $11,270 $7,051 62.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 75 121 $16,940 $6,724 39.7%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 18 18 $11,880 $4,781 40.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 22 22 $6,072 $1,686 27.8%
90662 Influenza vaccine split virus, preservative free Office 2022 21 22 $2,332 $1,482 63.5%
G0008 Administration of influenza virus vaccine Office 2022 23 24 $1,008 $660.72 65.5%
G0009 Administration of pneumococcal vaccine Office 2022 19 19 $798.00 $521.32 65.3%
83036 Hemoglobin a1c level Office 2022 31 36 $1,296 $345.25 26.6%
36415 Insertion of needle into vein for collection of blood sample Office 2022 40 43 $714.00 $127.59 17.9%
96372 Injection of drug or substance under skin or into muscle Office 2022 11 12 $588.00 $86.89 14.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 112 241 $49,646 $19,891 40.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 51 51 $12,750 $6,569 51.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 48 75 $10,500 $5,131 48.9%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2021 36 36 $7,624 $4,485 58.8%

About Dr. Cory Lemoine, DO

Dr. Cory Lemoine, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Broussard, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1760836597.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cory Lemoine, DO has received a total of $2,418 in payments from pharmaceutical and medical device companies, with $711.10 received in 2024. These payments were reported across 149 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,418).

As a Medicare-enrolled provider, Lemoine has provided services to 1,579 Medicare beneficiaries, totaling 2,127 services with total Medicare billing of $133,391. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

Products in Payments

  • MOUNJARO (Drug) $239.08
  • COLOGUARD DNA CAPTURE REAGENTS (Device) $209.07
  • JARDIANCE (Drug) $177.58
  • SHINGRIX (Biological) $175.72
  • VRAYLAR (Drug) $143.50
  • Cologuard Collection Kit (Device) $125.68
  • FARXIGA (Drug) $111.63
  • TRULICITY (Drug) $94.56
  • TRINTELLIX (Drug) $85.32
  • Otezla (Drug) $84.56
  • TRELEGY ELLIPTA (Drug) $82.96
  • Veozah (Drug) $80.86
  • Ozempic (Drug) $67.62
  • COLOGUARD (Device) $62.90
  • CHANTIX (Drug) $56.62
  • Rybelsus (Drug) $52.59
  • FREESTYLE LIBRE 3 (Device) $52.05
  • SOLIQUA 100/33 (Biological) $42.77
  • EMGALITY (Drug) $38.74
  • JORNAY PM (Drug) $36.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Broussard